Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
Cells
|
November 27, 2024
Synergistic Activation of VDR-RXR Heterodimers by Vitamin D and Rexinoids in Human Kidney and Brain Cells
Mobin Emran Doost, Jennifer Hong, Jennifer E Broatch, et al.
Frontiers in Immunology
|
February 14, 2022
Rexinoids Modulate Effector T Cell Expression of Mucosal Homing Markers CCR9 and α4β7 Integrin and Direct Their Migration <i>In Vitro</i>
Kavita R Manhas, Pamela A Marshall, Carl E Wagner, et al.
Journal of Medicinal Chemistry
|
June 27, 2003
Synthesis of 1-boraadamantaneamine derivatives with selective astrocyte vs C6 glioma antiproliferative activity. A novel class of anti-hepatitis C agents with potential to bind CD81
Carl E Wagner, Michael L Mohler, Gyong Suk Kang, et al.
Steroids
|
April 29, 2018
A novel gene expression analytics-based approach to structure aided design of rexinoids for development as next-generation cancer therapeutics
Bentley J Hanish, Jennifer F Hackney Price, Ichiro Kaneko, et al.
Scientific Reports
|
January 8, 2022
The rexinoid V-125 reduces tumor growth in preclinical models of breast and lung cancer
Lyndsey A Reich, Jessica A Moerland, Ana S Leal, et al.
ACS Chemical Neuroscience
|
February 11, 2021
Evaluating Novel RXR Agonists That Induce ApoE and Tyrosine Hydroxylase in Cultured Human Glioblastoma Cells
Sanchita Mallick, Pamela A Marshall, Carl E Wagner, et al.
Hepatology (Baltimore, Md.)
|
December 20, 2015
Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma
Yoshifumi Iwagami, Chiung-Kuei Huang, Mark J Olsen, et al.
Pharmacology Research & Perspectives
|
June 4, 2015
Analysis of differential secondary effects of novel rexinoids: select rexinoid X receptor ligands demonstrate differentiated side effect profiles
Pamela A Marshall, Peter W Jurutka, Carl E Wagner, et al.
Cells
|
July 13, 2026
1,25-Dihydroxyvitamin D Induces a NURR1-Tyrosine Hydroxylase Transcriptional Axis Modulated by Rexinoid/RXR Signaling in Parkinson's Disease-Relevant Human Neural Cell Models
Michael A Sausedo, Sanchita Mallick, Zhela L Sabir, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
February 15, 2019
Testing Novel Pyrimidinyl Rexinoids: A New Paradigm for Evaluating Rexinoids for Cancer Prevention
Di Zhang, Ana S Leal, Sarah Carapellucci, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
Cells
|
November 27, 2024
Synergistic Activation of VDR-RXR Heterodimers by Vitamin D and Rexinoids in Human Kidney and Brain Cells
Mobin Emran Doost, Jennifer Hong, Jennifer E Broatch, et al.
Frontiers in Immunology
|
February 14, 2022
Rexinoids Modulate Effector T Cell Expression of Mucosal Homing Markers CCR9 and α4β7 Integrin and Direct Their Migration <i>In Vitro</i>
Kavita R Manhas, Pamela A Marshall, Carl E Wagner, et al.
Journal of Medicinal Chemistry
|
June 27, 2003
Synthesis of 1-boraadamantaneamine derivatives with selective astrocyte vs C6 glioma antiproliferative activity. A novel class of anti-hepatitis C agents with potential to bind CD81
Carl E Wagner, Michael L Mohler, Gyong Suk Kang, et al.
Steroids
|
April 29, 2018
A novel gene expression analytics-based approach to structure aided design of rexinoids for development as next-generation cancer therapeutics
Bentley J Hanish, Jennifer F Hackney Price, Ichiro Kaneko, et al.
Scientific Reports
|
January 8, 2022
The rexinoid V-125 reduces tumor growth in preclinical models of breast and lung cancer
Lyndsey A Reich, Jessica A Moerland, Ana S Leal, et al.
ACS Chemical Neuroscience
|
February 11, 2021
Evaluating Novel RXR Agonists That Induce ApoE and Tyrosine Hydroxylase in Cultured Human Glioblastoma Cells
Sanchita Mallick, Pamela A Marshall, Carl E Wagner, et al.
Hepatology (Baltimore, Md.)
|
December 20, 2015
Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma
Yoshifumi Iwagami, Chiung-Kuei Huang, Mark J Olsen, et al.
Pharmacology Research & Perspectives
|
June 4, 2015
Analysis of differential secondary effects of novel rexinoids: select rexinoid X receptor ligands demonstrate differentiated side effect profiles
Pamela A Marshall, Peter W Jurutka, Carl E Wagner, et al.
Cells
|
July 13, 2026
1,25-Dihydroxyvitamin D Induces a NURR1-Tyrosine Hydroxylase Transcriptional Axis Modulated by Rexinoid/RXR Signaling in Parkinson's Disease-Relevant Human Neural Cell Models
Michael A Sausedo, Sanchita Mallick, Zhela L Sabir, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
February 15, 2019
Testing Novel Pyrimidinyl Rexinoids: A New Paradigm for Evaluating Rexinoids for Cancer Prevention
Di Zhang, Ana S Leal, Sarah Carapellucci, et al.
Page
of 3